Robert W. Baird Lowers Dyne Therapeutics (NASDAQ:DYN) Price Target to $32.00
Dyne Therapeutics (NASDAQ:DYN – Get Free Report) had its target price cut by equities researchers at Robert W. Baird from $46.00 to $32.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Robert W. Baird’s price objective would indicate a potential upside of 196.85% from […]
Dyne Therapeutics (NASDAQ:DYN – Get Free Report) had its target price cut by equities researchers at Robert W. Baird from $46.00 to $32.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Robert W. Baird’s price objective would indicate a potential upside of 196.85% from […]
